new research: ICON7 Results May Change Practice in Ovarian Cancer | Cancer Survivors Network Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, December 18, 2010

new research: ICON7 Results May Change Practice in Ovarian Cancer | Cancer Survivors Network



OncologySTAT: Dr. Cervantes, what were the most important studies in ovarian cancer that were presented at this year’s ESMO Congress?


Dr. Andres Cervantes: For me, the most important study was the ICON7 trial, which was presented during the presidential session of the ESMO Congress.1 It was a very important presentation because the paper is the result of a randomized phase III trial by a large cooperative group. The study was done within the Gynaecologic Cancer InterGroup, with an effort of several other cooperative groups, including the British MRC/NCRI, the leading group. However, also involved were the German AGO-OVAR, the Australian and New Zealand ANZGOG, the Spanish group for research in gynecologic and ovarian cancer, GEICO, the French GINECO, the Scandinavian group NSGO, and the National Cancer Institute of Canada, NCIC....cont'd

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.